Tubulis GmbH
Tubulis - Model Tub-tag -Conjugation Platform
FromTubulis GmbH
The Tub-tag® conjugation platform was inspired by microtubule biology and adds a significant amount of stability to the ADC product candidates by modulating the antibody to provide a highly beneficial microenvironment for the payload. Moreover, the human-derived nature of the Tub-tag® lowers the risk of the ADC causing unwanted immune reactions.
Most popular related searches
-
Homogeneous ADCs with improved therapeutic index
-
Defined drug loads with high DAR flexibility
-
Tub-tag® provides highly beneficial microenvironment for site-specific payload conjugation
